Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-24-080961

Chief Scientific Officer acquired 2,360 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Michaelson Jennifer Chief Scientific Officer 2024-07-01 Grant or award +2,360 $9.00 $21,240 131,942 D
Loading xslF345X05/ownership.xml…